BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.39, $0.16 better than the analyst estimate of $0.23. Revenue for the quarter came in at $94.5 million versus the consensus estimate of $91.58 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.